Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential

Affiliations

¹ Infectious Diseases Society of America, Arlington.
² UPMC Center for Health Security, University of Pittsburgh Medical Center, Pennsylvania.
³ Department of Medicine, University of California-Irvine Department of Microbiology and Molecular Genetics, University of California-Irvine.
⁴ Department of Molecular Microbiology and Immunology, Baltimore, Maryland.
⁵ NVS Influenza Vaccines, Cambridge.
⁶ Public Health-Seattle and King County, Seattle University of Washington, Seattle.
⁷ University of Virginia School of Medicine, Charlottesville.
⁸ Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School.
⁹ Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
¹⁰ Department of Epidemiology, Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
¹¹ Department of Pediatrics, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City.
¹² Department of Medicine, Center for International Security and Cooperation at Stanford University, California Department of Microbiology and Immunology, Center for International Security and Cooperation at Stanford University, California.

Editorial

Gregory M Frank et al. J Infect Dis. 2016.

. 2016 May 1;213(9):1359-61.

doi: 10.1093/infdis/jiv474. Epub 2015 Sep 27.

¹ Infectious Diseases Society of America, Arlington.
² UPMC Center for Health Security, University of Pittsburgh Medical Center, Pennsylvania.
³ Department of Medicine, University of California-Irvine Department of Microbiology and Molecular Genetics, University of California-Irvine.
⁴ Department of Molecular Microbiology and Immunology, Baltimore, Maryland.
⁵ NVS Influenza Vaccines, Cambridge.
⁶ Public Health-Seattle and King County, Seattle University of Washington, Seattle.
⁷ University of Virginia School of Medicine, Charlottesville.
⁸ Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School.
⁹ Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
¹⁰ Department of Epidemiology, Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
¹¹ Department of Pediatrics, Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City.
¹² Department of Medicine, Center for International Security and Cooperation at Stanford University, California Department of Microbiology and Immunology, Center for International Security and Cooperation at Stanford University, California.

No abstract available

Keywords: gain-of-function; health policy; influenza; potential pandemic pathogens; science policy.

Comment on

Gain-of-Function Research and the Relevance to Clinical Practice.
Kilianski A, Nuzzo JB, Modjarrad K. Kilianski A, et al. J Infect Dis. 2016 May 1;213(9):1364-9. doi: 10.1093/infdis/jiv473. Epub 2015 Sep 27. J Infect Dis. 2016. PMID: 26416657 Free PMC article. Review.

1. Casadevall A, Imperiale MJ. Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion. MBio 2014; 5:e01730–14. - PMC - PubMed
1. Duprex WP, Fouchier RA, Imperiale MJ, Lipsitch M, Relman DA. Gain-of-function experiments: time for a real debate. Nat Rev Microbiol 2015; 13:58–64. - PMC - PubMed
1. Lipsitch M, Inglesby TV. Moratorium on research intended to create novel potential pandemic pathogens. MBio 2014; 5:e02366-14. - PMC - PubMed
1. Wain-Hobson S. The irrationality of GOF avian influenza virus research. Front Public Health 2014; 2:77. - PMC - PubMed
1. Kilianski A, Nuzzo JB, Modjarrad K. Gain-of-function research and the relevance to clinical practice. J Infect Dis 2016; 213:1364–9. - PMC - PubMed